Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$7.26 USD
+0.35 (5.07%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $7.28 +0.02 (0.28%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $0.02 | 0.00% |
Earnings Summary
For their last quarter, Aurinia Pharmaceuticals (AUPH) reported earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This reflects a positive earnings surprise of 100.00%. Look out for AUPH's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of $0.02 per share, reflecting a year-over-year increase of 122.22%.
Earnings History
Price & Consensus
Zacks News for AUPH
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
AUPH: What are Zacks experts saying now?
Zacks Private Portfolio Services